Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo
Authors
Keywords
-
Journal
Emerging Microbes & Infections
Volume 11, Issue 1, Pages 873-884
Publisher
Informa UK Limited
Online
2022-03-07
DOI
10.1080/22221751.2022.2049983
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of yellow fever virus transmission in the Asia-Pacific region
- (2020) Lucy de Guilhem de Lataillade et al. Nature Communications
- Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
- (2019) Caroline S. de Freitas et al. PLoS Neglected Tropical Diseases
- Structure of the yellow fever NS5 protein reveals conserved drug targets shared among flaviviruses
- (2019) Anna Dubankova et al. ANTIVIRAL RESEARCH
- Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus
- (2019) Robin D.V. Kleinert et al. Viruses-Basel
- Biosensor-Based Active Ingredients Recognition System for Screening STAT3 Ligands from Medical Herbs
- (2018) Langdong Chen et al. ANALYTICAL CHEMISTRY
- Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe
- (2018) Florian Douam et al. TRENDS IN MICROBIOLOGY
- Structural and Functional Basis of the Fidelity of Nucleotide Selection by Flavivirus RNA-Dependent RNA Polymerases
- (2018) Barbara Selisko et al. Viruses-Basel
- Structural basis for the inhibition of poxvirus assembly by the antibiotic rifampicin
- (2018) Damià Garriga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic and epidemiological monitoring of yellow fever virus transmission potential
- (2018) N. R. Faria et al. SCIENCE
- Molecular epidemiology of dengue, yellow fever, Zika and Chikungunya arboviruses: An update
- (2018) Adriana Higuera et al. ACTA TROPICA
- Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?
- (2017) Omamah Alfarisi et al. Expert Review of Clinical Pharmacology
- A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein
- (2016) Fang Guo et al. JOURNAL OF VIROLOGY
- Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS
- (2016) Zhenjian He et al. JOURNAL OF VIROLOGY
- Rifamycins, Alone and in Combination
- (2016) David M. Rothstein Cold Spring Harbor Perspectives in Medicine
- Yellow fever
- (2015) Thomas P. Monath et al. JOURNAL OF CLINICAL VIROLOGY
- BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model
- (2014) Justin G. Julander et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses
- (2014) Fang Guo et al. ANTIVIRAL RESEARCH
- Regulation of Flavivirus RNA synthesis and replication
- (2014) Barbara Selisko et al. Current Opinion in Virology
- Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells
- (2013) Fabrizio Dal Piaz et al. Journal of Proteomics
- Flavivirus Entry Receptors: An Update
- (2013) Manuel Perera-Lecoin et al. Viruses-Basel
- Evolutionary and ecological factors underlying the tempo and distribution of yellow fever virus activity
- (2012) Christine V.F. Carrington et al. INFECTION GENETICS AND EVOLUTION
- Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
- (2012) S. E. Dorman et al. JOURNAL OF INFECTIOUS DISEASES
- The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever
- (2011) Emily S Jentes et al. LANCET INFECTIOUS DISEASES
- Identification and Characterization of the Host Protein DNAJC14 as a Broadly Active Flavivirus Replication Modulator
- (2011) Zhigang Yi et al. PLoS Pathogens
- Identification of Inhibitors of Yellow Fever Virus Replication Using a Replicon-Based High-Throughput Assay
- (2009) C. G. Patkar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106
- (2008) J. G. Julander et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started